Literature DB >> 20709367

Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events.

Matthew Gissel1, Anetta Undas, Agnieszka Slowik, Kenneth G Mann, Kathleen E Brummel-Ziedins.   

Abstract

INTRODUCTION: More than 80% of cerebrovascular events are ischemic and largely thromboembolic by nature. We evaluated whether plasma factor composition and thrombin generation dynamics might be a contributor to the thrombotic phenotype of ischemic cerebrovascular events.
MATERIALS AND METHODS: We studied (1) 100 patients with acute ischemic stroke (n=50) or transient ischemic attack (TIA) (n=50) within the first 24 hours from symptom onset, and (2) 100 individuals 1 to 4 years following ischemic stroke (n=50) or TIA (n=50). The tissue factor pathway to thrombin generation was simulated with a mathematical model using plasma levels of clotting factors (F)II, V, VII, VIII, IX, X, antithrombin and free tissue factor pathway inhibitor (TFPI).
RESULTS: The plasma levels of free TFPI, FII, FVIII, and FX were higher, while antithrombin was lower, in the acute patients compared to the previous event group (all p≤0.02). Thrombin generation during acute events was enhanced, with an 11% faster maximum rate, a 15% higher maximum level and a 26% larger total production (all p<0.01). The increased thrombin generation in acute patients was determined by higher FII and lower antithrombin, while increased free TFPI mediated this effect. When the groups are classified by etiology, all stroke sub-types except cardioembolic have increased TFPI and decreased AT and total thrombin produced.
CONCLUSION: Augmented thrombin generation in acute stroke/TIA is to some extent determined by altered plasma levels of coagulation factors.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20709367      PMCID: PMC2946539          DOI: 10.1016/j.thromres.2010.07.002

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  24 in total

1.  Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation.

Authors:  Claes Ladenvall; Ann Gils; Katarina Jood; Christian Blomstrand; Paul J Declerck; Christina Jern
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02-01       Impact factor: 8.311

Review 2.  Hypercoagulable states and strokes.

Authors:  Nena Matijevic; Kenneth K Wu
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

3.  A model for the tissue factor pathway to thrombin. II. A mathematical simulation.

Authors:  K C Jones; K G Mann
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

4.  Thrombin generation profiles in deep venous thrombosis.

Authors:  K E Brummel-Ziedins; C Y Vossen; S Butenas; K G Mann; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2005-11       Impact factor: 5.824

5.  The tissue factor pathway in ischemic stroke.

Authors:  Murray J Adams; Jim Thom; Graeme J Hankey; Ross Baker; Grace Gilmore; Janelle Staton; John W Eikelboom
Journal:  Blood Coagul Fibrinolysis       Date:  2006-10       Impact factor: 1.276

6.  The plasma hemostatic proteome: thrombin generation in healthy individuals.

Authors:  K Brummel-Ziedins; C Y Vossen; F R Rosendaal; K Umezaki; K G Mann
Journal:  J Thromb Haemost       Date:  2005-07       Impact factor: 5.824

7.  Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation.

Authors:  Gregor Hron; Marietta Kollars; Bernd R Binder; Sabine Eichinger; Paul A Kyrle
Journal:  JAMA       Date:  2006-07-26       Impact factor: 56.272

8.  Alterations of haemostatic markers in various subtypes and phases of stroke.

Authors:  M Yamazaki; S Uchiyama; S Maruyama
Journal:  Blood Coagul Fibrinolysis       Date:  1993-10       Impact factor: 1.276

9.  Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition.

Authors:  K Brummel-Ziedins; A Undas; T Orfeo; M Gissel; S Butenas; K Zmudka; K G Mann
Journal:  J Thromb Haemost       Date:  2007-10-15       Impact factor: 5.824

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  7 in total

1.  Mathematical model of thrombin generation and bleeding phenotype in Amish carriers of Factor IX:C deficiency vs. controls.

Authors:  S Gupta; M C Bravo; M Heiman; C Nakar; K Brummel-Ziedins; C H Miller; A Shapiro
Journal:  Thromb Res       Date:  2019-08-08       Impact factor: 3.944

2.  The influence of prophylactic factor VIII in severe haemophilia A.

Authors:  M Gissel; M F Whelihan; L A Ferris; K G Mann; G E Rivard; K E Brummel-Ziedins
Journal:  Haemophilia       Date:  2011-09-07       Impact factor: 4.287

Review 3.  Modeling thrombin generation: plasma composition based approach.

Authors:  Kathleen E Brummel-Ziedins; Stephen J Everse; Kenneth G Mann; Thomas Orfeo
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

4.  Factor Xa generation by computational modeling: an additional discriminator to thrombin generation evaluation.

Authors:  Kathleen E Brummel-Ziedins; Thomas Orfeo; Matthew Gissel; Kenneth G Mann; Frits R Rosendaal
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

5.  Low thrombin generation predicts poor prognosis in ischemic stroke patients after thrombolysis.

Authors:  Renáta Hudák; Edina G Székely; Katalin R Kovács; Attila Nagy; Gergely Hofgárt; Ervin Berényi; László Csiba; János Kappelmayer; Zsuzsa Bagoly
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

6.  The prothrombotic phenotypes in familial protein C deficiency are differentiated by computational modeling of thrombin generation.

Authors:  Kathleen E Brummel-Ziedins; Thomas Orfeo; Peter W Callas; Matthew Gissel; Kenneth G Mann; Edwin G Bovill
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

7.  In silico thrombin generation: Plasma composition imbalance and mortality in human immunodeficiency virus.

Authors:  Kathleen E Brummel-Ziedins; Matthew Gissel; Jacqueline Neuhaus; Álvaro H Borges; David R Chadwick; Sean Emery; James D Neaton; Russell P Tracy; Jason V Baker
Journal:  Res Pract Thromb Haemost       Date:  2018-09-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.